Indian drugmakers turn to buffers stocks, contract tweaks to tackle Iran war fallout- Moneycontrol.com
Indian pharmaceutical majors have warned that a prolonged West Asia conflict could push up drug costs for patients and healthcare systems, as rising freight and raw material expenses start creeping into company balance sheets. Executives at Dr Reddy's Laboratories and Cipla say they are, for now, absorbing a large part of the cost increases to ensure uninterrupted supply of medicines…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
